{"t": "D.C. Law 23-252. Insulin and Diabetes Device Affordability Amendment Act of 2020.", "p": "/us/dc/council/laws/23-252", "et": "document", "dj": "/us/dc/council/laws/23-252/index.json", "fh": "/us/dc/council/laws/23-252/index.full.html", "sc": "D.C. Law 23-252", "sp": "library|dclaws|23|permanent|D.C. Law 23-252", "sd": true, "c": [{"t": "\u00a7 2.", "p": "/us/dc/council/laws/23-252#\u00a72", "et": "section", "sc": "\u00a7 2", "sp": "library|dclaws|23|permanent|D.C. Law 23-252|2", "c": [{"t": "(a)", "p": "/us/dc/council/laws/23-252#\u00a72(a)", "et": "para", "sc": "\u00a7 2(a)", "c": [{"t": "(1)", "p": "/us/dc/council/laws/23-252#\u00a72(a)(1)", "et": "para", "sc": "\u00a7 2(a)(1)", "x": "New paragraphs (3A) and (3B) are added to read as follows:"}, {"t": "(2)", "p": "/us/dc/council/laws/23-252#\u00a72(a)(2)", "et": "para", "sc": "\u00a7 2(a)(2)", "x": "A new paragraph (9A) is added to read as follows:"}], "x": "Section 2 (D.C. Official Code \u00a7 48-855.01) is amended as follows:"}, {"t": "(b)", "p": "/us/dc/council/laws/23-252#\u00a72(b)", "et": "para", "sc": "\u00a7 2(b)", "x": "Section 3 (D.C. Official Code \u00a7 48-855.02) is amended by striking the phras"}, {"t": "(c)", "p": "/us/dc/council/laws/23-252#\u00a72(c)", "et": "para", "sc": "\u00a7 2(c)", "x": "Section 4 (D.C. Official Code \u00a7 48-855.03) is amended by striking the phras"}, {"t": "(d)", "p": "/us/dc/council/laws/23-252#\u00a72(d)", "et": "para", "sc": "\u00a7 2(d)", "x": "A new section 3a is added to read as follows:"}], "x": "The Specialty Drug Copayment Limitation Act of 2016, effective April 7, 201"}, {"t": "\u00a7 3. Fiscal impact statement.", "p": "/us/dc/council/laws/23-252#\u00a73", "et": "section", "sc": "\u00a7 3", "sp": "library|dclaws|23|permanent|D.C. Law 23-252|3"}, {"t": "\u00a7 4. Effective date.", "p": "/us/dc/council/laws/23-252#\u00a74", "et": "section", "sc": "\u00a7 4", "sp": "library|dclaws|23|permanent|D.C. Law 23-252|4"}]}